Pay in 4 interest-free payments of $6.22 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
What This Means for Metabolic Medicine I think the bigger story here isn't about any single drug
Retarutide (LY3437943) is a triple agonist peptide of glucagon receptor (GCGR), glucose-dependent insulin-promoting peptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R)
A welcome deal is only as good as its clarity: wagering targets, game weighting, contribution caps, and expiry windows should be written in plain language, not buried in footnotes
Of those that currently offer GLP-1 drug coverage only for diabetes, 20% are considering offering the drugs for weight loss (up from 9% in 2024)
Wegovy injection (semaglutide) is a prescription medication approved for chronic weight management in adults and certain adolescents with obesity, or in adults who are overweight with at least one weight-related condition such as high blood pressure, type 2 diabetes, or high cholesterol
US$ 24.82
US$ 29.33
US$ 26.59
US$ 27.74
US$ 24.06
